EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IL-37 links ACLY-centered lipid metabolic reprogramming to myeloid immunosuppression in pancreatic ductal adenocarcinoma

Ziwei Liu, Guangchao Sun, Na Xu, Yuying Chen, Mingxin Dong, Xiao Geng, Baichuan Chen, Wensen Liu, Ruixin Lin

International Immunopharmacology · 2026-12 · 191 · 117589

DOI: 10.1016/j.intimp.2026.117589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Ziwei Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital of Jilin University, Changchun, Jilin, China. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the role of IL-37 in PDAC and its association with lipid metabolic reprogramming and tumour immune suppression. Bioinformatic analyses, paired clinical specimens, IL-37 gain- and loss-of-function models, and in vitro and in vivo functional assays were used to characterize the role of IL-37 in PDAC. Tumour immune profiles and metabolic alterations were assessed by flow cytometry, immunofluorescence, molecular analyses, and untargeted metabolomics. Bone marrow-derived MDSC assays and pharmacological AKT inhibition were used for mechanistic validation, and the effects of ACLY inhibition and Gr-1 blockade were further evaluated in vivo. IL-37 was upregulated in PDAC tissues and cell lines and was associated with shorter overall survival. IL-37 overexpression enhanced cell viability, clonogenicity, migration, invasion, and tumour growth, whereas IL-37 knockdown produced the opposite effects. IL-37 overexpression was also associated with increased CD11b+Gr-1+ myeloid-derived suppressor cell accumulation and impaired CD8+ T-cell infiltration. Tumour-derived IL-37-associated signals further promoted MDSC generation and preferentially shifted the population toward M-MDSCs in vitro. Metabolomic and molecular analyses revealed an ACLY-centred lipid metabolic programme involving increased ACLY, FASN, and SPHK1 expression and alterations in acetyl-CoA, palmitate, and sphingosine-1-phosphate. IL-37 enhanced AKT phosphorylation, whereas AKT inhibition attenuated the upregulation of ACLY, FASN, and SPHK1, supporting a functional role for AKT signalling in this metabolic phenotype. ACLY inhibition, particularly in combination with Gr-1 blockade, reduced lipid accumulation and myeloid-cell infiltration, restored CD8+ T-cell responses, and suppressed tumour growth. IL-37 promotes PDAC progression in association with AKT-related signalling, ACLY-centred lipid metabolic reprogramming and an immunosuppressive tumour microenvironment. Combined targeting of lipid metabolism and immunosuppressive myeloid cells may represent a therapeutic strategy for IL-37-high PDAC.

Schlagwörter

Stichwörter der Autor:innen

ATP citrate lyaseImmune evasionImmunometabolic remodellingInterleukin-37Myeloid-derived suppressor cellsPancreatic ductal adenocarcinoma

Autor:innen und Institutionen

  • The Second Hospital of Jilin University, Changchun, Jilin, China.
  • Basic College of Medicine, Jilin Medical University, Jilin, China.
  • State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun, China.
  • The Second Hospital of Jilin University, Changchun, Jilin, China. Electronic address: linrx@jlu.edu.cn.

Zitieren

APA

Liu, Z., Sun, G., Xu, N., Chen, Y., Dong, M., Geng, X., Chen, B., Liu, W., & Lin, R. (2026). IL-37 links ACLY-centered lipid metabolic reprogramming to myeloid immunosuppression in pancreatic ductal adenocarcinoma. International Immunopharmacology, 191, 117589. https://doi.org/10.1016/j.intimp.2026.117589

Vancouver

Liu Z, Sun G, Xu N, Chen Y, Dong M, Geng X, et al. IL-37 links ACLY-centered lipid metabolic reprogramming to myeloid immunosuppression in pancreatic ductal adenocarcinoma. International Immunopharmacology. 2026;191:117589. doi:10.1016/j.intimp.2026.117589

BibTeX
@article{Liu2026,
  author = {Liu, Ziwei and Sun, Guangchao and Xu, Na and Chen, Yuying and Dong, Mingxin and Geng, Xiao and Chen, Baichuan and Liu, Wensen and Lin, Ruixin},
  title = {IL-37 links ACLY-centered lipid metabolic reprogramming to myeloid immunosuppression in pancreatic ductal adenocarcinoma},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {191},
  pages = {117589},
  doi = {10.1016/j.intimp.2026.117589}
}
Kostenlos starten →